Abstract
Intrinsic chemical instability and physical instability of therapeutic proteins require appropriate formulations and processes to ensure their efficacy and safety. Recent concerns on possible immunogenicity of the structurally altered protein molecules emphasize relevance of the product quality. Advances in the protein and material researches enable rational design of the aqueous solution and solid protein formulations. This chapter describes the basic process to develop the formulations and choice of excipients that protect the proteins from various stresses during the manufacturing and storage.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arakawa T, Prestrelski SJ, Kenney WC et al (2001) Factors affecting short-term and long-term stabilities of proteins. Adv Drug Deliv Rev 46:307–326
Manning MC, Chou DK, Murphy BM et al (2010) Stability of protein pharmaceuticals: an update. Pharm Res 27:544–575
Chang LL, Pikal MJ (2009) Mechanisms of protein stabilization in the solid state. J Pharm Sci 98:2886–2908
Mahler HC, Friess W, Grauschopf U et al (2009) Protein aggregation: pathways, induction factors and analysis. J Pharm Sci 98:2909–2934
Volkin DB, Sanyal G, Burke CJ et al (2002) Preformulation studies as an essential guide to formulation development and manufacture of protein pharmaceuticals. Pharm Biotechnol 14:1–46
Samra HS, He F (2012) Advancements in high throughput biophysical technologies: applications for characterization and screening during early formulation development of monoclonal antibodies. Mol Pharm 9:696–707
Nail SL, Jiang S, Chongprasert S et al (2002) Fundamentals of freeze-drying. Pharm Biotechnol 14:281–360
Simpson RJ (2010) Stabilization of proteins for storage. Cold Spring Harb Protoc 79
Lee JC, Timasheff SN (1981) The stabilization of proteins by sucrose. J Biol Chem 256:7193–7201
Carpenter JF, Prestrelski SJ, Dong A (1998) Application of infrared spectroscopy to development of stable lyophilized protein formulations. Eur J Pharm Biopharm 45:231–238
Stotz CE, Winslow SL, Houchin ML et al (2004) Degradation pathways for lyophilized peptides and proteins. In: Costantino HR, Pikal MJ (eds) Lyophilization of pharmaceutical products. AAPS Press, Arlington, pp 443–480
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Izutsu, Ki. (2014). Stabilization of Therapeutic Proteins in Aqueous Solutions and Freeze-Dried Solids: An Overview. In: Labrou, N. (eds) Protein Downstream Processing. Methods in Molecular Biology, vol 1129. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-977-2_31
Download citation
DOI: https://doi.org/10.1007/978-1-62703-977-2_31
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-976-5
Online ISBN: 978-1-62703-977-2
eBook Packages: Springer Protocols